Stathmin and phospho-stathmin protein signature is associated with survival outcomes of breast cancer patients.
about
Ophiobolin A Induces Autophagy and Activates the Mitochondrial Pathway of Apoptosis in Human Melanoma CellsHispidin induces autophagic and necrotic death in SGC-7901 gastric cancer cells through lysosomal membrane permeabilization by inhibiting tubulin polymerization.Novel indolyl-chalcones target stathmin to induce cancer cell death.miR-193b directly targets STMN1 and inhibits the malignant phenotype in colorectal cancerHigh expression of microRNA-454 is associated with poor prognosis in triple-negative breast cancer.Stathmin decreases cholangiocarcinoma cell line sensitivity to staurosporine-triggered apoptosis via the induction of ERK and Akt signaling.Stathmin1 overexpression in hypopharyngeal squamous cell carcinoma: A new promoter in FaDu cell proliferation and migration.The Atypical Kinase RIOK1 Promotes Tumor Growth and Invasive Behavior.Elevated STMN1 promotes tumor growth and invasion in endometrial carcinoma.Overexpression of stathmin plays a pivotal role in the metastasis of esophageal squamous cell carcinoma.Stathmin 1 expression predicts prognosis and benefits from adjuvant chemotherapy in patients with gallbladder carcinoma.STMN1 is Overexpressed in Adrenocortical Carcinoma and Promotes a More Aggressive Phenotype In Vitro.miR-34a Regulates Expression of the Stathmin-1 Oncoprotein and Prostate Cancer Progression.High STMN1 Expression is Associated with Cancer Progression and Chemo-Resistance in Lung Squamous Cell Carcinoma.MiR-770 suppresses the chemo-resistance and metastasis of triple negative breast cancer via direct targeting of STMN1.
P2860
Q28554921-DF874A56-106A-4282-A5B7-98ECE8B75220Q33688901-A438AAE8-9518-4851-AE11-84DA819CDE33Q35961195-F05DCBDE-50C5-429C-8C94-0C96C36052E8Q37447860-27295096-C3FA-484A-AE07-C3F26E1F8B8FQ37662154-539A7F79-AC80-4AAB-8B52-2A7E31887E67Q37716616-4D90EF62-EDF8-42E0-8DD6-96AF9BF84267Q38729446-3E9DCDDC-E64A-4AE3-9438-FA73183666B1Q38788696-8C40234E-58C9-4F68-8ADD-B5DF1F2B1A5DQ40056028-0052A4DB-B083-4DE1-8703-456A336D7D79Q41867931-8F7BD162-DDA0-457C-8B9E-FE7751A6FB81Q47172693-4683F92D-F791-441B-B99F-56B78F591B67Q47321196-6F0C43AA-DF2B-400F-A5AD-B079DDEAE198Q47660322-7DC0FCC0-C344-4B6E-AAF3-B8BA8EFBC2A1Q47769528-C1EEB6C9-7EDD-4D37-BF49-CAE80908B899Q48263230-DC83141F-5791-416D-9763-D4BB80463619
P2860
Stathmin and phospho-stathmin protein signature is associated with survival outcomes of breast cancer patients.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Stathmin and phospho-stathmin ...... mes of breast cancer patients.
@ast
Stathmin and phospho-stathmin ...... mes of breast cancer patients.
@en
type
label
Stathmin and phospho-stathmin ...... mes of breast cancer patients.
@ast
Stathmin and phospho-stathmin ...... mes of breast cancer patients.
@en
prefLabel
Stathmin and phospho-stathmin ...... mes of breast cancer patients.
@ast
Stathmin and phospho-stathmin ...... mes of breast cancer patients.
@en
P2093
P2860
P356
P1433
P1476
Stathmin and phospho-stathmin ...... omes of breast cancer patients
@en
P2093
Xia-Ying Kuang
Yi-Rong Liu
Yi-Zi Zheng
Zhi-Ming Shao
P2860
P304
22227-22238
P356
10.18632/ONCOTARGET.4276
P407
P50
P577
2015-09-01T00:00:00Z